Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data

Peer Review reports

Original Submission
9 Oct 2020	Submitted	Original manuscript
3 Nov 2020	Reviewed	Reviewer Report
10 Nov 2020	Reviewed	Reviewer Report
3 Dec 2020	Author responded	Author comments - Margaret von Mehren
Resubmission - Version 2
3 Dec 2020	Submitted	Manuscript version 2
21 Dec 2020	Reviewed	Reviewer Report
8 Jan 2021	Reviewed	Reviewer Report
27 Jan 2021	Reviewed	Reviewer Report
21 Feb 2021	Reviewed	Reviewer Report
3 Mar 2021	Author responded	Author comments - Margaret von Mehren
Resubmission - Version 3
3 Mar 2021	Submitted	Manuscript version 3
Publishing
4 Mar 2021	Editorially accepted
19 Mar 2021	Article published	10.1186/s12885-021-08013-1

Back to article page